help button home button The Oncologist
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow eLetters: Submit a response to this article
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hall, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hall, P. A.
The Oncologist, Vol. 3, No. 4, 218-224, August 1998
© 1998 AlphaMed Press


Original Papers

p53: The Challenge of Linking Basic Science and Patient Management

Peter A. Hall

Department of Cellular & Molecular Pathology, University of Dundee, Ninewells Hospital and Medical School, Dundee, Scotland, United Kingdom

Correspondence: Peter A. Hall, M.D., Ph.D., Department of Cellular & Molecular Pathology, University of Dundee, Ninewells Hospital and Medical School, Dundee, DD1 9SY Scotland, United Kingdom. Telephone: +44-1382-632169; Fax: +44-1382-566933; e-mail: p.a.hall{at}dundee.ac.uk

Abnormalities of the p53 tumor suppressor gene are the single most common molecular abnormality seen in human cancer, being found in more than 50% of malignancies. Considerable evidence indicates that the product of this gene has critical roles in coordinating the response of cells to a diverse range of environmental stresses. Loss of p53 function is associated with loss of normal cell cycle control, diminished apoptosis, and genomic instability and is strongly associated with the neoplastic phenotype. We have a detailed knowledge of the biochemical properties of p53 and its activity as a transcription factor regulating diverse aspects of cellular function, but the in vivo physiological relevance of many of these remains uncertain. Nevertheless, p53 represents a highly significant potential target for novel therapeutic intervention; however, the further development of clinical applications and novel therapeutic strategies utilizing our knowledge of p53 is absolutely contingent upon bridging the gap between our biochemical understanding and our much less well-developed insights into the role of p53 in relevant physiological systems in vivo.

Key Words. p53 • Stress responses • Physiology • Biochemistry • Therapy







HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
THE ONCOLOGIST STEM CELLS CME ALPHAMED PRESS JOURNALS


Copyright © 1998 by AlphaMed Press.